Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,531.61
1,563.99
1,087.65
1,299.29
1,108.83
882.98
970.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,531.61
1,563.99
1,087.65
1,299.29
1,108.83
882.98
970.11
Raw Material Cost
342.03
312.34
417.96
334.47
292.23
281.36
325.46
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.06
6.76
7.63
8.05
8.34
8.51
8.95
Selling and Distribution Expenses
564.57
453.39
576.03
569.40
499.54
398.37
494.49
Other Expenses
34.27
21.49
24.96
18.78
18.64
13.07
23.24
Total Expenditure (Excl Depreciation)
1,256.36
987.38
1,251.17
1,099.77
986.52
818.98
1,061.32
Operating Profit (PBDIT) excl Other Income
275.2
576.5999999999999
-163.5
199.5
122.30000000000001
64
-91.19999999999999
Other Income
82.76
45.54
141.02
11.75
-1.16
14.61
133.42
Operating Profit (PBDIT)
379.29
682.01
27.28
269.03
170.90
143.45
65.78
Interest
7.06
6.76
7.63
8.05
8.34
8.51
8.95
Exceptional Items
0.00
0.00
0.00
0.00
0.13
-0.13
-0.03
Gross Profit (PBDT)
1,189.58
1,251.64
669.69
964.83
816.60
601.62
644.65
Depreciation
83.08
83.08
76.28
76.28
65.42
65.42
66.30
Profit Before Tax
289.15
592.17
-56.62
184.71
97.28
69.39
-9.51
Tax
-16.64
38.33
-28.41
23.30
7.30
11.83
-32.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
296.62
554.61
-35.72
166.48
114.92
46.61
13.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
296.62
554.61
-35.72
166.48
114.92
46.61
13.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-0.02
0.00
-0.00
0.00
-0.01
0.55
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
296.62
554.59
-35.72
166.48
114.92
46.60
14.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,815.86
4,844.41
4,289.83
4,227.09
4,064.66
4,115.93
4,213.33
Earnings per share (EPS)
0.26
0.5
-0.03
0.15
0.1
0.04
0.01
Diluted Earnings per share
0.26
0.5
-0.03
0.15
0.1
0.04
0.01
Operating Profit Margin (Excl OI)
13.94%
35.38%
-17.47%
13.93%
9.62%
7.18%
-13.81%
Gross Profit Margin
24.3%
43.17%
1.81%
20.09%
14.67%
15.27%
5.85%
PAT Margin
19.37%
35.46%
-3.28%
12.81%
10.36%
5.28%
1.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 38.13% vs 20.26% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 158.14% vs 58.92% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 72.28% vs 23.46% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -14.46% vs -8.79% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Haisco Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,531.61
0
1,531.61
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,531.61
0
1,531.61
Raw Material Cost
342.03
0
342.03
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.06
0
7.06
Selling and Distribution Expenses
564.57
0
564.57
Other Expenses
34.27
0.00
34.27
Total Expenditure (Excl Depreciation)
1,256.36
0
1,256.36
Operating Profit (PBDIT) excl Other Income
275.25
0.00
275.25
Other Income
82.76
0
82.76
Operating Profit (PBDIT)
379.29
0
379.29
Interest
7.06
0
7.06
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,189.58
0
1,189.58
Depreciation
83.08
0
83.08
Profit Before Tax
289.15
0
289.15
Tax
-16.64
0
-16.64
Provisions and contingencies
0
0
0.00
Profit After Tax
296.62
0
296.62
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
296.62
0
296.62
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
296.62
0
296.62
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,815.86
0
4,815.86
Earnings per share (EPS)
0.26
0
0.26
Diluted Earnings per share
0.26
0
0.26
Operating Profit Margin (Excl OI)
13.94%
0%
0.00
13.94%
Gross Profit Margin
24.30%
0%
0.00
24.30%
PAT Margin
19.37%
0%
0.00
19.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 153.16 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -2.07% vs 43.80% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 38.13% vs 20.26% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 29.66 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -46.52% vs 1,653.50% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 158.14% vs 58.92% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.65 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -53.42% vs 659.81% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 72.28% vs 23.46% in Jun 2025
Quarterly - Interest
Interest 0.71 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 4.41% vs -10.53% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -14.46% vs -8.79% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.94%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
